(Q42444725)

English

Combination treatment with bortezomib and thiostrepton is effective against tumor formation in mouse models of DEN/PB-induced liver carcinogenesis

scientific article published on 16 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 October 2017

Combination treatment with bortezomib and thiostrepton is effective against tumor formation in mouse models of DEN/PB-induced liver carcinogenesis (English)

1 reference

Europe PubMed Central

31 October 2017

1 reference

based on heuristic

inferred from title

Jennifer Landolfi

5

object named as

Jennifer Landolfi

1 reference

Europe PubMed Central

31 October 2017

author name string

Ming Wang

1

1 reference

Europe PubMed Central

31 October 2017

Marianna Halasi

2

1 reference

Europe PubMed Central

31 October 2017

Kasim Kabirov

3

1 reference

Europe PubMed Central

31 October 2017

Aryamitra Banerjee

4

1 reference

Europe PubMed Central

31 October 2017

Alexander V Lyubimov

6

1 reference

Europe PubMed Central

31 October 2017

Andrei L Gartel

7

1 reference

Europe PubMed Central

31 October 2017

publication date

16 August 2012

1 reference

Europe PubMed Central

31 October 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

31 October 2017

11

1 reference

Europe PubMed Central

31 October 2017

18

1 reference

Europe PubMed Central

31 October 2017

3370-3372

1 reference

Europe PubMed Central

31 October 2017

Combination with bortezomib enhances the antitumor effects of nanoparticle-encapsulated thiostrepton

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

Antiplasmodial thiostrepton derivatives: proteasome inhibitors with a dual mode of action.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

28 May 2018

Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3466545

16 August 2018

Identifiers

10.4161/CC.21290

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42444725&oldid=1959694646"